Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

John Corboy

Concepts (369)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Multiple Sclerosis
47
2024
380
8.280
 Why?
Multiple Sclerosis, Relapsing-Remitting
14
2024
69
3.100
 Why?
Neurology
10
2018
85
2.490
 Why?
Immunosuppressive Agents
10
2024
666
1.800
 Why?
Immunologic Factors
11
2020
220
1.700
 Why?
Neuromyelitis Optica
4
2023
114
1.240
 Why?
Natalizumab
11
2021
46
1.000
 Why?
Recurrence
7
2024
953
0.790
 Why?
Diagnostic Errors
2
2017
151
0.770
 Why?
Internship and Residency
5
2011
951
0.750
 Why?
Drug Substitution
2
2019
46
0.690
 Why?
Fingolimod Hydrochloride
5
2020
30
0.680
 Why?
Rituximab
4
2020
149
0.650
 Why?
Brain
14
2021
2373
0.640
 Why?
Data Collection
4
2011
636
0.630
 Why?
Dementia, Vascular
3
2009
17
0.620
 Why?
Drug Monitoring
1
2019
184
0.600
 Why?
Early Medical Intervention
1
2017
51
0.560
 Why?
Medication Adherence
2
2019
538
0.560
 Why?
Early Diagnosis
2
2017
220
0.550
 Why?
Glatiramer Acetate
6
2019
20
0.530
 Why?
Physicians
4
2016
776
0.530
 Why?
Calcinosis
2
2009
242
0.510
 Why?
Antibodies, Monoclonal, Humanized
8
2023
667
0.500
 Why?
Postural Balance
3
2018
182
0.500
 Why?
Humans
79
2024
115741
0.490
 Why?
Magnetic Resonance Imaging
23
2023
3122
0.470
 Why?
Fatigue
3
2018
296
0.420
 Why?
Dimethyl Fumarate
3
2020
10
0.390
 Why?
Immunoglobulin G
4
2023
781
0.390
 Why?
Practice Guidelines as Topic
1
2018
1405
0.360
 Why?
Multiple Sclerosis, Chronic Progressive
3
2020
25
0.350
 Why?
Withholding Treatment
2
2021
69
0.350
 Why?
Middle Aged
37
2021
27069
0.330
 Why?
Psychiatry
2
2009
155
0.330
 Why?
Adult
41
2023
30789
0.310
 Why?
Cysts
1
2009
93
0.310
 Why?
Demyelinating Diseases
4
2019
75
0.310
 Why?
Education, Medical
1
2011
225
0.300
 Why?
Autoantibodies
3
2023
1360
0.300
 Why?
Certification
1
2008
90
0.300
 Why?
Clinical Trials as Topic
3
2016
941
0.280
 Why?
Education
2
2007
99
0.280
 Why?
Central Nervous System Cysts
1
2006
12
0.280
 Why?
Cerebral Arteries
1
2006
55
0.270
 Why?
Myelin-Oligodendrocyte Glycoprotein
2
2023
43
0.270
 Why?
Single-Blind Method
3
2023
255
0.270
 Why?
Cerebrovascular Disorders
1
2006
83
0.260
 Why?
Societies, Medical
4
2019
684
0.260
 Why?
Treatment Outcome
12
2023
9162
0.260
 Why?
Female
46
2023
60018
0.260
 Why?
DNA, Viral
2
1998
351
0.260
 Why?
HIV Long Terminal Repeat
2
1997
7
0.260
 Why?
Databases, Factual
3
2016
1139
0.250
 Why?
Double-Blind Method
4
2023
1660
0.240
 Why?
Male
36
2023
56050
0.240
 Why?
Drug Industry
2
2016
104
0.230
 Why?
Conflict of Interest
2
2016
120
0.220
 Why?
Encephalomyelitis, Autoimmune, Experimental
1
2023
50
0.210
 Why?
Quality of Health Care
2
2017
576
0.200
 Why?
B-Lymphocytes
5
2023
773
0.200
 Why?
Mental Disorders
2
2007
902
0.200
 Why?
Brain Neoplasms
4
2016
980
0.200
 Why?
Lymphoma
2
2005
178
0.200
 Why?
Interferon beta-1a
2
2019
12
0.190
 Why?
Central Nervous System Neoplasms
2
2005
125
0.190
 Why?
Neuroimaging
1
2023
248
0.190
 Why?
Education, Medical, Continuing
2
2015
119
0.180
 Why?
Disease Progression
4
2021
2423
0.180
 Why?
Lymphopenia
1
2020
50
0.180
 Why?
Agammaglobulinemia
1
2020
29
0.180
 Why?
Referral and Consultation
1
2005
646
0.180
 Why?
Interferon-gamma
1
2023
726
0.170
 Why?
Neutropenia
1
2020
127
0.170
 Why?
Serum Sickness
1
2019
7
0.170
 Why?
Indans
1
2019
9
0.170
 Why?
Oxadiazoles
1
2019
32
0.170
 Why?
Diagnosis, Differential
4
2023
1357
0.170
 Why?
Adjuvants, Immunologic
3
2015
206
0.150
 Why?
Educational Measurement
3
2015
262
0.150
 Why?
Salvage Therapy
1
2019
128
0.150
 Why?
Lymphoma, AIDS-Related
1
1998
13
0.150
 Why?
Physician-Patient Relations
2
2016
465
0.150
 Why?
Hematopoietic Stem Cell Transplantation
2
2019
519
0.150
 Why?
Drug-Related Side Effects and Adverse Reactions
1
2020
242
0.150
 Why?
Eye Movements
1
2018
53
0.150
 Why?
Herpesvirus 8, Human
1
1998
63
0.150
 Why?
AIDS Dementia Complex
1
1997
50
0.150
 Why?
Diffuse Cerebral Sclerosis of Schilder
1
2017
4
0.150
 Why?
Central Nervous System
2
2005
239
0.150
 Why?
Patient Selection
2
2015
654
0.150
 Why?
Sarcoma, Kaposi
1
1998
69
0.140
 Why?
Herpesvirus 4, Human
1
2018
123
0.140
 Why?
HIV Seropositivity
1
1998
110
0.140
 Why?
Young Adult
6
2023
10518
0.140
 Why?
Neurologists
1
2016
18
0.140
 Why?
Herpesviridae Infections
1
1998
138
0.140
 Why?
Costs and Cost Analysis
1
2017
200
0.130
 Why?
Cost-Benefit Analysis
2
2016
548
0.130
 Why?
Aged
8
2023
19294
0.130
 Why?
Estriol
1
2015
5
0.130
 Why?
T-Lymphocytes
1
2023
1756
0.130
 Why?
Dizziness
2
2018
70
0.130
 Why?
Verbal Learning
2
2013
63
0.130
 Why?
Corpus Callosum
2
2006
57
0.130
 Why?
Follow-Up Studies
6
2020
4442
0.120
 Why?
Diffusion Magnetic Resonance Imaging
2
2006
85
0.120
 Why?
Trust
1
2016
108
0.120
 Why?
Retrospective Studies
9
2020
12633
0.120
 Why?
Ethics, Medical
1
2015
70
0.120
 Why?
Mesenchymal Stem Cell Transplantation
1
2014
37
0.120
 Why?
Exercise Therapy
1
2018
351
0.120
 Why?
Insurance, Health
1
2016
246
0.110
 Why?
Medication Reconciliation
1
2013
25
0.110
 Why?
CD40 Antigens
1
2014
82
0.110
 Why?
T-Lymphocytes, Helper-Inducer
1
2014
129
0.110
 Why?
Anti-Inflammatory Agents
2
2006
448
0.110
 Why?
JC Virus
1
2013
23
0.110
 Why?
Population Surveillance
1
2016
395
0.110
 Why?
Sensation Disorders
1
2012
30
0.100
 Why?
Glioma
1
2016
296
0.100
 Why?
Memory Disorders
1
2013
155
0.100
 Why?
Immune Reconstitution Inflammatory Syndrome
1
2012
18
0.100
 Why?
Immunoglobulin Heavy Chains
3
2007
72
0.100
 Why?
Leukoencephalopathy, Progressive Multifocal
1
2012
38
0.100
 Why?
Lymphoma, T-Cell, Peripheral
1
2012
15
0.100
 Why?
Optic Nerve
2
2005
65
0.100
 Why?
T-Lymphocyte Subsets
1
2014
383
0.100
 Why?
Quality of Life
3
2021
2388
0.090
 Why?
Gadolinium
4
2018
79
0.090
 Why?
Learning
1
2015
358
0.090
 Why?
Biomarkers
3
2014
3471
0.090
 Why?
Self-Assessment
1
2011
63
0.090
 Why?
Academies and Institutes
1
2011
44
0.090
 Why?
Nervous System Diseases
1
2013
253
0.090
 Why?
Nerve Regeneration
1
2010
53
0.090
 Why?
Fatal Outcome
3
2006
286
0.090
 Why?
Diagnostic Tests, Routine
1
2011
88
0.090
 Why?
Antigens, CD19
3
2007
97
0.090
 Why?
Leukocytosis
1
2010
35
0.090
 Why?
Severity of Illness Index
3
2014
2586
0.090
 Why?
Exercise Test
1
2012
539
0.090
 Why?
Cranial Nerve Neoplasms
1
1989
6
0.090
 Why?
Hemangioma, Cavernous
1
1989
15
0.090
 Why?
Optic Chiasm
1
1989
18
0.080
 Why?
United States
7
2019
12304
0.080
 Why?
Central Nervous System Infections
1
2010
36
0.080
 Why?
Disease Management
1
2013
563
0.080
 Why?
Guidelines as Topic
1
2011
248
0.080
 Why?
Spinal Cord
3
2023
351
0.080
 Why?
Neuroprotective Agents
1
2009
105
0.080
 Why?
Physical Therapy Modalities
1
2011
269
0.080
 Why?
Practice Patterns, Physicians'
1
2016
1180
0.080
 Why?
Workload
1
2009
133
0.070
 Why?
Hospital-Physician Relations
1
2007
2
0.070
 Why?
Antibodies, Monoclonal
2
2011
1265
0.070
 Why?
Neuropsychological Tests
2
2013
920
0.070
 Why?
Immunoglobulin Variable Region
2
2004
72
0.070
 Why?
HIV-1
1
1992
771
0.070
 Why?
Headache Disorders
1
2006
12
0.070
 Why?
Vasculitis, Central Nervous System
1
2006
17
0.070
 Why?
Nerve Fibers, Myelinated
1
2006
41
0.070
 Why?
Huntington Disease
1
2007
38
0.070
 Why?
Medical Records
1
2007
157
0.070
 Why?
Glial Fibrillary Acidic Protein
1
2006
79
0.070
 Why?
Syndrome
2
2023
339
0.070
 Why?
International Classification of Diseases
1
2007
118
0.070
 Why?
Contrast Media
3
2018
369
0.070
 Why?
Methylprednisolone
1
2006
83
0.070
 Why?
Antibody Formation
1
2007
273
0.070
 Why?
Intracranial Hemorrhages
1
2006
76
0.070
 Why?
Aquaporin 4
1
2006
86
0.070
 Why?
Fellowships and Scholarships
1
2009
241
0.070
 Why?
Herpes Zoster
1
2010
333
0.070
 Why?
Canada
2
2019
335
0.060
 Why?
Surveys and Questionnaires
4
2016
4669
0.060
 Why?
DNA Mutational Analysis
1
2006
372
0.060
 Why?
RNA, Messenger
1
1992
2574
0.060
 Why?
Health Care Surveys
1
2007
538
0.060
 Why?
Patient Compliance
1
2009
524
0.060
 Why?
Erythrocytes
1
2010
589
0.060
 Why?
Cognition Disorders
1
2009
475
0.060
 Why?
Teaching
1
2007
224
0.060
 Why?
Affect
1
2007
244
0.060
 Why?
Neurologic Examination
1
2005
116
0.060
 Why?
Analysis of Variance
3
2015
1230
0.060
 Why?
Program Evaluation
1
2009
836
0.060
 Why?
Central Nervous System Diseases
1
2005
61
0.060
 Why?
Neutrophils
1
2010
1172
0.060
 Why?
Simvastatin
1
2004
59
0.060
 Why?
Faculty, Medical
1
2006
234
0.060
 Why?
Ophthalmoplegia
1
2003
8
0.060
 Why?
Proteoglycans
1
2004
107
0.060
 Why?
Diagnostic Techniques, Ophthalmological
1
2003
36
0.060
 Why?
Adolescent
7
2021
17922
0.050
 Why?
B-Lymphocyte Subsets
1
2003
68
0.050
 Why?
Cyclophosphamide
1
2003
218
0.050
 Why?
Anticoagulants
1
2006
549
0.050
 Why?
Radiography
1
2005
828
0.050
 Why?
Cross-Sectional Studies
1
2012
4448
0.050
 Why?
Academic Medical Centers
1
2005
414
0.050
 Why?
Students, Medical
1
2006
277
0.050
 Why?
Dementia
1
2005
185
0.050
 Why?
Membrane Glycoproteins
1
2004
431
0.050
 Why?
Infusions, Intravenous
1
2023
374
0.050
 Why?
Lymphoma, B-Cell
2
2005
86
0.050
 Why?
Patient Outcome Assessment
1
2023
123
0.050
 Why?
Clinical Competence
1
2008
912
0.050
 Why?
Peptides
3
2013
864
0.050
 Why?
Time Factors
4
2018
6171
0.050
 Why?
Pain
1
2007
712
0.050
 Why?
Schools, Medical
1
2002
123
0.050
 Why?
Disability Evaluation
2
2014
271
0.050
 Why?
Molecular Sequence Data
3
2004
2790
0.050
 Why?
Consensus
1
2023
537
0.050
 Why?
Antibodies, Antinuclear
1
2001
60
0.050
 Why?
Atrophy
1
2021
152
0.050
 Why?
Child
5
2016
18503
0.050
 Why?
Mobility Limitation
1
2020
60
0.040
 Why?
Antibodies, Viral
1
2023
527
0.040
 Why?
Interferon-beta
2
2011
79
0.040
 Why?
Lymphocyte Activation
1
2003
1057
0.040
 Why?
Lipids
1
2023
588
0.040
 Why?
Maintenance Chemotherapy
1
2019
22
0.040
 Why?
Induction Chemotherapy
1
2019
56
0.040
 Why?
Cerebral Infarction
1
1998
39
0.040
 Why?
Cell Separation
2
2014
293
0.040
 Why?
Transplantation, Autologous
1
2019
173
0.040
 Why?
HIV Seronegativity
1
1998
24
0.040
 Why?
Genes, myc
1
1998
47
0.040
 Why?
Astrocytoma
1
1998
109
0.040
 Why?
Risk Assessment
1
2006
2990
0.040
 Why?
In Situ Hybridization
1
2018
298
0.040
 Why?
Gene Library
1
1997
117
0.040
 Why?
Gene Rearrangement
1
1998
135
0.040
 Why?
Breast Neoplasms
1
2008
1872
0.040
 Why?
Real-Time Polymerase Chain Reaction
1
2018
317
0.030
 Why?
Syndecan-1
2
2007
28
0.030
 Why?
Mutation
1
2006
3364
0.030
 Why?
Viral Load
1
2018
405
0.030
 Why?
Flow Cytometry
2
2014
1083
0.030
 Why?
Drug Administration Schedule
1
2018
724
0.030
 Why?
Colorado
1
2005
4116
0.030
 Why?
Child, Preschool
3
2016
9138
0.030
 Why?
Polymerase Chain Reaction
1
1998
1001
0.030
 Why?
Survival Analysis
1
2018
1219
0.030
 Why?
Sequence Analysis, DNA
1
1997
732
0.030
 Why?
Health Knowledge, Attitudes, Practice
2
2016
1200
0.030
 Why?
Patient Care Team
1
2019
521
0.030
 Why?
Incidence
1
2020
2335
0.030
 Why?
Base Sequence
1
1997
2114
0.030
 Why?
Congresses as Topic
1
2015
204
0.030
 Why?
Propylene Glycols
1
2013
26
0.030
 Why?
Ocular Physiological Phenomena
1
1992
11
0.030
 Why?
Sphingosine
1
2013
32
0.030
 Why?
HLA-DR Antigens
1
2014
221
0.030
 Why?
beta-Galactosidase
1
1992
63
0.030
 Why?
Drug Therapy, Combination
1
2015
962
0.030
 Why?
Quality-Adjusted Life Years
1
2013
103
0.030
 Why?
Markov Chains
1
2013
114
0.030
 Why?
Mice
2
2023
15052
0.030
 Why?
Mice, Inbred DBA
1
1992
173
0.030
 Why?
Animals
3
2023
32104
0.030
 Why?
Haplotypes
1
2014
457
0.030
 Why?
Mental Recall
1
2013
173
0.030
 Why?
Comparative Effectiveness Research
1
2013
130
0.030
 Why?
Organ Specificity
1
1992
273
0.030
 Why?
Reference Values
1
2013
750
0.020
 Why?
Depression
2
2011
1147
0.020
 Why?
CD3 Complex
1
2012
92
0.020
 Why?
Intestine, Small
1
1992
125
0.020
 Why?
Ki-67 Antigen
1
2012
104
0.020
 Why?
Thymus Gland
1
1992
299
0.020
 Why?
Mitoxantrone
1
2011
12
0.020
 Why?
Patient Participation
1
2015
363
0.020
 Why?
Hematologic Tests
1
2011
22
0.020
 Why?
Muscle Stretching Exercises
1
2011
17
0.020
 Why?
Clinical Laboratory Techniques
1
2011
87
0.020
 Why?
Randomized Controlled Trials as Topic
2
2006
1218
0.020
 Why?
Aged, 80 and over
2
2016
6423
0.020
 Why?
Physical Endurance
1
2011
223
0.020
 Why?
Recombinant Fusion Proteins
1
1992
616
0.020
 Why?
Amino Acid Sequence
2
2004
2000
0.020
 Why?
Prevalence
1
2016
2269
0.020
 Why?
Acyclovir
1
2010
100
0.020
 Why?
Respiratory Function Tests
1
2011
535
0.020
 Why?
Spinal Cord Neoplasms
1
1989
40
0.020
 Why?
Cell Count
1
2010
305
0.020
 Why?
History, 19th Century
1
2009
56
0.020
 Why?
Pilot Projects
2
2004
1384
0.020
 Why?
Neoplasms, Multiple Primary
1
1989
52
0.020
 Why?
Injections
1
2009
161
0.020
 Why?
History, 21st Century
1
2009
162
0.020
 Why?
Autoimmunity
1
2014
822
0.020
 Why?
Electrocardiography
1
2011
564
0.020
 Why?
History, 20th Century
1
2009
273
0.020
 Why?
Mice, Transgenic
1
1992
1970
0.020
 Why?
Age of Onset
1
2009
450
0.020
 Why?
Gene Expression
1
1992
1436
0.020
 Why?
Memory
1
2009
212
0.020
 Why?
Walking
1
2011
425
0.020
 Why?
Health
1
2007
74
0.020
 Why?
CD8-Positive T-Lymphocytes
1
2012
693
0.020
 Why?
Prognosis
2
2006
3343
0.020
 Why?
Association Learning
1
2007
60
0.020
 Why?
Cerebral Ventricles
1
2006
47
0.020
 Why?
Motor Skills
1
2007
80
0.020
 Why?
Hospitalization
1
2015
1765
0.020
 Why?
Phenotype
1
2014
2839
0.020
 Why?
Herpesvirus 3, Human
1
2010
381
0.020
 Why?
Immunologic Memory
1
2007
314
0.020
 Why?
Hypothalamus
1
2006
150
0.020
 Why?
Social Support
1
2009
539
0.020
 Why?
Genetics
1
2005
27
0.020
 Why?
Neurosciences
1
2005
20
0.020
 Why?
Models, Theoretical
1
2009
520
0.020
 Why?
Clinical Protocols
1
2006
233
0.020
 Why?
Syndecans
1
2004
5
0.020
 Why?
Internet
1
2009
602
0.010
 Why?
Image Interpretation, Computer-Assisted
1
2006
243
0.010
 Why?
Anisotropy
1
2004
62
0.010
 Why?
Antiviral Agents
1
2010
649
0.010
 Why?
Risk Factors
2
2008
8702
0.010
 Why?
Plasma Cells
1
2004
57
0.010
 Why?
Immune System
1
2005
173
0.010
 Why?
Gene Rearrangement, B-Lymphocyte, Light Chain
1
2003
4
0.010
 Why?
Gene Rearrangement, B-Lymphocyte, Heavy Chain
1
2003
12
0.010
 Why?
Videotape Recording
1
2003
30
0.010
 Why?
Infrared Rays
1
2003
21
0.010
 Why?
Feasibility Studies
1
2006
748
0.010
 Why?
Meningitis, Viral
1
2003
21
0.010
 Why?
Lymphoma, Large B-Cell, Diffuse
1
2005
97
0.010
 Why?
Saccades
1
2003
35
0.010
 Why?
Astrocytes
1
2005
163
0.010
 Why?
Antilymphocyte Serum
1
2003
66
0.010
 Why?
Oligoclonal Bands
1
2003
21
0.010
 Why?
Mice, Inbred C57BL
1
1992
4773
0.010
 Why?
Microglia
1
2005
203
0.010
 Why?
Antigens, CD34
1
2003
90
0.010
 Why?
Clone Cells
1
2003
248
0.010
 Why?
Whole-Body Irradiation
1
2003
72
0.010
 Why?
Receptors, Antigen, B-Cell
1
2003
107
0.010
 Why?
Immunoglobulins
1
2003
147
0.010
 Why?
Observer Variation
1
2003
301
0.010
 Why?
Longitudinal Studies
1
2009
2420
0.010
 Why?
Tomography, X-Ray Computed
1
2012
2393
0.010
 Why?
Sex Characteristics
1
2007
641
0.010
 Why?
Age Factors
1
2009
2911
0.010
 Why?
Infant
1
2015
7979
0.010
 Why?
Administration, Oral
1
2004
734
0.010
 Why?
Urinary Tract Infections
1
2003
136
0.010
 Why?
Cohort Studies
1
2011
4949
0.010
 Why?
Biopsy
1
2005
1056
0.010
 Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2003
930
0.010
 Why?
Immunoglobulin kappa-Chains
1
2001
18
0.010
 Why?
Cytomegalovirus Infections
1
2003
182
0.010
 Why?
Predictive Value of Tests
1
2006
1825
0.010
 Why?
Acute Disease
1
2003
914
0.010
 Why?
Immunoglobulin Fab Fragments
1
2001
69
0.010
 Why?
Combined Modality Therapy
1
2003
1127
0.010
 Why?
Research
1
2003
396
0.010
 Why?
Lung
1
1992
3673
0.010
 Why?
Survival Rate
1
2003
1651
0.010
 Why?
Sensitivity and Specificity
1
2003
1730
0.010
 Why?
Arachnoid
1
1998
9
0.010
 Why?
Models, Biological
1
2005
1646
0.010
 Why?
Case-Control Studies
1
2004
3037
0.010
 Why?
Aging
1
2007
1632
0.010
 Why?
Reproducibility of Results
1
2003
2824
0.010
 Why?
Corboy's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (369) concept(s)
_
Co-Authors Expand Description
See all (34) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)